Swisse Ultiboost Zinc + Vitamin C + Garlic Australia - English - Department of Health (Therapeutic Goods Administration)

swisse ultiboost zinc + vitamin c + garlic

swisse wellness pty ltd - allium sativum,calcium ascorbate dihydrate,zinc amino acid chelate -

GALLIUM- gallium citrate ga-67 injection United States - English - NLM (National Library of Medicine)

gallium- gallium citrate ga-67 injection

lantheus medical imaging, inc. - gallium citrate ga-67 (unii: 4ljk511z86) (gallium cation ga-67 - unii:99t03j52w0) - gallium cation ga-67 2.0 mci in 1 ml - gallium citrate ga 67 injection may be useful in demonstrating the presence of the following malignancies: hodgkins disease, lymphomas and bronchogenic carcinoma. positive ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state. gallium citrate ga 67 injection may be useful as an aid in detecting some acute inflammatory lesions. none known.

GALLIUM CITRATE GA-67 injection, solution United States - English - NLM (National Library of Medicine)

gallium citrate ga-67 injection, solution

curium us llc - gallium chloride ga-67 (unii: a04b19o2b0) (gallium cation ga-67 - unii:99t03j52w0) - gallium cation ga-67 2 mci in 1 ml - gallium citrate ga 67 injection may be useful to demonstrate the presence and extent of hodgkin's disease, lymphoma, and bronchogenic carcinoma. positive gallium ga-67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state. gallium citrate ga 67 injection may be useful as an aid in detecting some acute inflammatory lesions. none.

Cenovis Echinacea, Garlic, Zinc & C Australia - English - Department of Health (Therapeutic Goods Administration)

cenovis echinacea, garlic, zinc & c

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - allium sativum, quantity: 8.33 mg (equivalent: allium sativum, qty 100 mg); ascorbic acid, quantity: 500 mg; zinc gluconate, quantity: 14 mg (equivalent: zinc, qty 2 mg); echinacea purpurea, quantity: 22.22 mg (equivalent: echinacea purpurea, qty 1000 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; dl-alpha-tocopherol; garlic bulb powder; croscarmellose sodium; vanillin; maize starch; silicon dioxide; povidone; macrogol 400; hypromellose; magnesium stearate; microcrystalline cellulose; crospovidone - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support healthy immune system function ; decrease/reduce/relieve common cold duration ; decrease/reduce/relieve the severity of common cold symptoms ; relieve symptoms of mild upper respiratory tract infections

DANMOT HERBALIX CHELATION FORMULA tablet bulk Australia - English - Department of Health (Therapeutic Goods Administration)

danmot herbalix chelation formula tablet bulk

danmot pty ltd - chromium amino acid chelate, quantity: 2 mg; ginkgo biloba, quantity: 630 microgram (equivalent: ginkgo biloba, qty 5 mg); iron amino acid chelate, quantity: 2 mg; manganese amino acid chelate, quantity: 20 mg (equivalent: manganese, qty 2 mg); zinc amino acid chelate, quantity: 20 mg; allium sativum, quantity: 3.57 mg (equivalent: allium sativum, qty 25 mg); sodium molybdate, quantity: 10 microgram (equivalent: molybdenum, qty 3.9 microgram); fucus vesiculosus, quantity: 2 mg (equivalent: fucus vesiculosus - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; magnesium stearate; soy polysaccharide; povidone; colloidal anhydrous silica; powdered cellulose; dextrin; ethylcellulose; fractionated coconut oil; alginic acid; hypromellose; iron oxide red; maize starch; dl-alpha-tocopherol; silicon dioxide; hydrolysed gelatin; hydrogenated soya oil; sucrose; ascorbyl palmitate; sodium ascorbate; potable water; calcium phosphate; gelatin - multivitamins, minerals, amino acids and herbal supplement.

GALLIUM (GA 67) CITRATE Israel - English - Ministry of Health

gallium (ga 67) citrate

isorad ltd, israel - gallium (67ga) citrate; sodium citrate - solution for injection - gallium (67ga) citrate 1.5 - 2 mci; sodium citrate 1.5 - 2 mg - gallium (67ga) citrate - gallium (67ga) citrate - inflammatory lesions and abscesses. primary and metastatic tumors hodgkin's disease. lymphomas and brochogenic carcinoma.

NUTRA-LIFE ESTER-C ADVANCED IMMUNE Australia - English - Department of Health (Therapeutic Goods Administration)

nutra-life ester-c advanced immune

vitaco health australia pty ltd - allium sativum,calcium ascorbate dihydrate,calcium carbonate,calcium l-threonate,olea europaea,zinc glycinate -

Gallium (Ga67) Citrate injection Ireland - English - HPRA (Health Products Regulatory Authority)

gallium (ga67) citrate injection

curium netherlands b.v. - gallium (67 ga) citrate - solution for injection - 37 megabecquerel(s)/millilitre - other diagnostic radiopharmaceuticals for inflammation and infection detection; gallium (67ga) citrate

ALLIUM- allium cepa tablet United States - English - NLM (National Library of Medicine)

allium- allium cepa tablet

standard homeopathic company - allium cepa whole (unii: 8p2vlg2456) (allium cepa whole - unii:8p2vlg2456) - allium cepa whole 30 [hp_x] in 1 g - runny nose,cold or hay fever

GALLIUM GA-68 PSMA-11- gallium ga-68 gozetotide injection, solution United States - English - NLM (National Library of Medicine)

gallium ga-68 psma-11- gallium ga-68 gozetotide injection, solution

ucsf radiopharmaceutical facility - gallium ga-68 gozetotide (unii: zj0ekr6m10) (gallium ga-68 gozetotide - unii:zj0ekr6m10) - gallium ga 68 gozeotide injection is indicated for positron emission tomography (pet) of prostate-specific membrane antigen (psma) positive lesions in men with prostate cancer: - with suspected metastasis who are candidates for initial definitive therapy. - with suspected recurrence based on elevated serum prostate-specific antigen (psa) level. none risk summary gallium ga 68 gozetotide injection is not indicated for use in females. there are no available data with gallium ga 68 gozetotide injection use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. all radiopharmaceuticals, including gallium ga 68 gozetotide injection, have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose. animal reproduction studies have not been conducted with gallium ga 68 gozetotide injection. risk summary gallium ga 68 gozetotide injection is not indicated for use in females. there ar